Publications by authors named "L Caro"

Claim this Profile
E
Efficacy and safety of obeldesivir in low-risk, non-hospitalised patients with COVID-19 (OAKTREE): a phase 3, randomised, double-blind, placebo-controlled study.
Onyema Ogbuagu, Jason D Goldman, Robert L Gottlieb, Upinder Singh, Masaharu Shinkai, Luzelena Caro

Lancet Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Drug-Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS-CoV-2, in Healthy Participants.
Jack Chang, Aryun Kim, Rita Humeniuk, Naveed A Shaik, Helen Winter, Luzelena Caro

Clin Transl Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
software: new developments in small- and wide-angle X-ray scattering data analysis for scanning mode and grazing-incidence geometry.
Francesco Scattarella, Davide Altamura, Teresa Sibillano, Liberato De Caro, Dritan Siliqi

J Appl Crystallogr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients with COVID-19 (BIRCH): a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
Anca Streinu-Cercel, Antonella Castagna, Shan-Chwen Chang, Yao-Shen Chen, Yiannis Koullias, Luzelena Caro

Clin Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An animal toxin-antidote system kills cells by creating a novel cation channel.
Lews Caro, Aguan D Wei, Christopher A Thomas, Galen Posch, Ahmet Uremis

PLoS Biol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis